Percutaneous Transluminal Angioplasty (PTA)
Sponsors
Baylor College of Medicine, Hull University Teaching Hospitals NHS Trust, University Health Network, Toronto, University Hospital, Saarland, Deutsches Herzzentrum Muenchen
Conditions
AngioplastyArterial Occlusive DiseaseArteriovenous FistulaeArteriovenous GraftChronic Limb-Threatening IschemiaDialysisFemoropopliteal DiseaseHeadache
Phase 1
Phase 2
Restenosis Following Paclitaxel Eluting Balloon Angioplasty of Hemodialysis Access Stenosis
CompletedNCT01001676
Start: 2012-02-29End: 2014-07-31Updated: 2014-11-17
Drug Eluting Balloon Angioplasty for Dialysis Access Treatment
CompletedNCT01174472
Start: 2010-03-31End: 2012-01-31Updated: 2012-01-23
Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache
NCT04352218
Start: 2020-09-30End: 2022-04-30Target: 60Updated: 2020-06-02
Phase 3
Phase 4
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
CompletedNCT00687076
Start: 2004-04-30End: 2010-12-31Updated: 2020-02-06
Paclitaxel Eluting Balloon and Conventional Balloon for In-Stent Restenosis of the Superficial Femoral Artery
NCT01083394
Start: 2010-03-31End: 2015-12-31Target: 70Updated: 2014-03-10
Unknown Phase
Trial of Nonsurgical Treatment of Intermittent Claudication Due to Femoro-popliteal Disease
CompletedNCT00798850
Start: 2002-08-31End: 2010-11-30Updated: 2019-07-15
Drug Eluting Balloon for Prevention of Hemodialysis Access Restenosis
CompletedNCT01928498
Start: 2013-10-31End: 2020-08-27Updated: 2021-01-20
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
CompletedNCT02228564
Start: 2014-09-30End: 2018-12-31Updated: 2020-10-08
The Role of Percutaneous Angioplasty in Ischemic Leg Ulcer Healing
CompletedNCT03057080
Start: 2009-06-01End: 2016-12-01Updated: 2017-02-17
Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease
Active, not recruitingNCT04475783
Start: 2021-04-13End: 2027-12-31Target: 478Updated: 2025-12-26
Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
RecruitingNCT06071429
Start: 2025-04-11End: 2032-03-01Target: 300Updated: 2026-02-06